|
SNAP29 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.198520E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.981700E-03 |
| Normal-vs-Stage2 |
7.193200E-01 |
| Normal-vs-Stage3 |
3.12639999999753E-06 |
| Normal-vs-Stage4 |
3.96140000002987E-06 |
| Stage1-vs-Stage2 |
2.776800E-01 |
| Stage1-vs-Stage3 |
2.206100E-02 |
| Stage1-vs-Stage4 |
6.204600E-03 |
| Stage2-vs-Stage3 |
2.514400E-02 |
| Stage2-vs-Stage4 |
6.603900E-03 |
| Stage3-vs-Stage4 |
3.116600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.003900E-04 |
| Normal-vs-AfricanAmerican |
4.007700E-02 |
| Normal-vs-Asian |
1.304800E-01 |
| Caucasian-vs-AfricanAmerican |
5.049400E-01 |
| Caucasian-vs-Asian |
4.366600E-01 |
| AfricanAmerican-vs-Asian |
2.941200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.768100E-04 |
| Normal-vs-Female |
8.043700E-04 |
| Male-vs-Female |
1.939960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.184400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.602810E-04 |
| Normal-vs-Age(61-80Yrs) |
2.884100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.461500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.523200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.545000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.062600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.989200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.293400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.446800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.996910E-03 |
| Classical-VS-Follicular |
8.962000E-02 |
| Classical-VS-Other |
3.337600E-01 |
| Classical-VS-Normal |
8.378900E-03 |
| Tall-VS-Follicular |
2.557800E-01 |
| Tall-VS-Other |
8.270400E-01 |
| Tall-VS-Normal |
1.68840000003279E-06 |
| Follicular-VS-Other |
4.735000E-01 |
| Follicular-VS-Normal |
1.264020E-03 |
| Other-VS-Normal |
1.742620E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.622000E-03 |
| Normal-vs-N1 |
1.028670E-04 |
| N0-vs-N1 |
6.790000E-02 |
|
|
